To assess the value of the Advanced Lung Cancer Inflammation Index in determining prognosis in patients with HFpEF, the researchers assessed patient data from the registry of Osaka’s Prospective Multicenter Observational Study of Patients with Heart Failure with Preserved Ejection Fraction.
The researchers created the survey to better understand health care providers’ experience with and comfortability with prescribing medication for lupus nephritis, as well as at what time during the disease process they prescribe medication.
To evaluate laboratory parameters during the early course of lupus nephritis and their association with long-term stability of kidney function, the researchers enrolled 433 patients between 2008 and 2017 and evaluated their laboratory results at baseline, 3, 6, and 12 months.
In this podcast, Heather Forkey, MD, discusses the mechanisms of burnout and how to use this understanding to restore resilience.
To build on their previous study, the researchers aimed to determine whether CD11b activation suppresses toll-like receptor-dependent proinflammatory signaling by controlling IL-1β, influences IL-1β through another mechanism, or does both.
An analysis of US claims data has identified the health care costs and utilization for patients with a new diagnosis of lupus nephritis.
To investigate the relevance of these lesions to the pathophysiology of lupus nephritis, researchers examined 205 kidney biopsy samples of patients with lupus nephritis and evaluated the clinical characteristics of the patients in whom these lesions were found.
In a recent study presented at the AHA’s Scientific Sessions, researchers examined the primary outcomes of number of deaths, adverse events, time to the first heart failure event, or a KCCQ score that had improved by at least 5 points.
To determine whether activation of the complement pathway contributes to thrombotic microangiopathy, researchers compared various blood tests and whole-genome sequencing results between patients with thrombotic microangiopathy with and without systemic lupus erythematosus.
To determine the in-vitro susceptibilities of delafloxacin and the comparator quinolones, the researchers tested clinical isolates from patients with community-acquired pneumonia and lower respiratory tract infections at 67 US-based medical centers that participated in the SENTRY Surveillance Program.